Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma

Anticancer Research

Volumn 28, Issue 3 B, 2008, Pages 1831-1836

  Ohtsuki, Kenichi ^a   Koyama, Fumikazu ^a   Tamura, Tomomi ^a   Enomoto, Yasunori ^a   Fujii, Hisao ^a   Mukogawa, Tomohide ^a   Nakagawa, Tadashi ^a   Uchimoto, Kazuaki ^a   Nakamura, Shinji ^a   Nonomura, Akitaka ^a   Nakajima, Yoshiyuki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; D2 40; Immunohistochemistry; Prognosis; Tumor budding

Indexed keywords

CYTOKERATIN ANTIBODY; EOSIN; HEMATOXYLIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER PATIENT; COLORECTAL CARCINOMA; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EOSINE YELLOWISH-(YS); FEMALE; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; STAINING AND LABELING;

EID: 45949094173     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Goldstein NS and Hart J: Histologic features associated with lymph node metastasis in stage Tl and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens. Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision. Am J Clin Pathol 111: 51-58, 1999.
2. Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K and Morimatsu M: An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 63: 539-543, 1989.
3. Okuyama T, Oya M and Ishikawa H: Budding as a risk factor for lymph node metastasis in pTl or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum 45: 628-634, 2002.
4. Masaki T, Matsuoka H, Sugiyama M, Abe N, Mori T, Atomi Y, Watanabe T, Nagawa H and Muto T: Budding as a useful determinant of the optimal treatment for Tl rectal carcinomas. Hepatogastroenterology 50: 388-391, 2003.
5. Okuyama T, Oya M and Yamaguchi M: Budding (sprouting) as a useful prognostic marker in colorectal mucinous carcinoma. Jpn J Clin Oncol 32: 412-416, 2002.
6. Tanaka M, Hashiguchi Y, Ueno H, Hase K and Mochizuki H: Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis Colon Rectum 46: 1054-1059, 2003.
7. Guzinska-Ustymowicz K: The role of tumour budding at the front of invasion and recurrence of rectal carcinoma. Anticancer Res 25: 1269-1272, 2005.
8. Okuyama T, Oya M and Ishikawa H: Budding as a useful prognostic marker in pT3 well-or moderately-differentiated rectal adenocarcinoma. J Surg Oncol 83: 42-47, 2003.
9. Ueno H, Murphy J, Jass JR, Mochizuki H and Talbot IC: Tumour budding as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40: 127-132, 2002.
10. Okuyama T, Nakamura T and Yamaguchi M: Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma. Dis Colon Rectum 46: 1400-1406, 2003.
11. Hase K, Shatney C, Johnson D, Trollope M and Vierra M: Prognostic value of tumor budding in patients with colorectal cancer. Dis Colon Rectum 36: 627-635, 1993.
12. Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, Matsukuma S, Kanai T, Kurihara H, Ozawa K, Yoshimura K and Bekku S: Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 127: 385-394, 2004.
13. Kazama S, Watanabe T, Ajioka Y, Kanazawa T and Nagawa H: Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer 94: 293-298, 2006.
14. Park KJ, Choi HJ, Roh MS, Kwon HC and Kim C: Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Rectum 48: 1597-1602, 2005.
15. Prall F, Nizze H and Barten M: Tumour budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology 47:17-24, 2005.
16. Sobin LH and Wittekind CH (eds.): UICC TNM Classification of Malignant Tumours, 6th Ed. New York, Wiley-Liss, 2002.
17. Imai T: The growth of human carcinoma. A morphological analysis. Fukuoka Igaku Zasshi 45: 13-43, 1954 (in Japanese).
18. Masaki T, Matsuoka H, Sugiyama M, Abe N, Goto A, Sakamoto A and Atomi Y: Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 84: 1317-1321, 2001.
19. Guzinska-Ustymowicz K, Zalewski B, Kasacka I, Piotrowski Z and Skrzydlewska E: Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding. Anticancer Res 24: 2847-2851, 2004.
20. Guzińska-Ustymowicz K: MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC). Anticancer Res 26: 1589-1594, 2006.